Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
14.10.2022 - - Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX - Company successfully launched AMPIVIEW gene expression platform powered by LoopRNA ISH technology - Continues to engage with ...
Source: wallstreet-online.de